Bolt Biotherapeutics Ownership | Who Owns Bolt Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Bolt Biotherapeutics Ownership Summary


Bolt Biotherapeutics is owned by 41.93% institutional investors, 7.11% insiders, and 50.97% retail investors. Vivo capital is the largest institutional shareholder, holding 9.18% of BOLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.46% of its assets in Bolt Biotherapeutics shares.

BOLT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBolt Biotherapeutics41.93%7.11%50.97%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vivo capital176.06K9.18%$936.66K
Sofinnova investments137.72K7.18%$732.68K
Citadel advisors2.37M6.22%$1.78M
Pivotal bioventure partners investment advisor94.57K4.93%$503.13K
Tang capital management66.88K3.49%$355.80K
Nan fung group58.35K3.04%$310.41K
Samsara biocapital48.83K2.55%$259.78K
Board of trustees of the leland stanford junior university35.98K1.88%$191.40K
Vanguard group34.23K1.79%$182.11K
Pfizer31.30K1.63%$166.54K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nan fung group58.35K0.52%$310.41K
Pivotal bioventure partners investment advisor94.57K0.29%$503.13K
Vivo capital176.06K0.08%$936.66K
Sofinnova investments137.72K0.04%$732.68K
Pfizer31.30K0.04%$166.54K
Samsara biocapital48.83K0.03%$259.78K
Board of trustees of the leland stanford junior university35.98K0.02%$191.40K
Tang capital management66.88K0.01%$355.80K
Shay capital15.96K0.01%$84.90K
Drw securities12.32K0.00%$65.55K

Top Buyers

HolderShares% AssetsChange
Shay capital15.96K0.01%15.96K
Drw securities12.32K0.00%12.32K
Blackrock267.07K-12.11K
Renaissance28.63K0.00%10.30K
Squarepoint ops14.84K0.00%2.45K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---1.54M
Acuitas investments---630.51K
Adage capital partners gp---500.00K
Newtyn management---468.91K
Susquehanna group, llp---147.93K

New Positions

HolderShares% AssetsChangeValue
Shay capital15.96K0.01%15.96K$84.90K
Drw securities12.32K0.00%12.32K$65.55K
Barclays6.00-6.00$32.00

Sold Out

HolderChange
Bnp paribas arbitrage, snc-1.00
Qube research-2.00
Fmr-121.00
Wells fargo & company/mn-211.00
Newedge advisors-483.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025244.35%804,036-9.28%41784.60%7250.00%8-61.90%
Jun 30, 202524-14.29%889,879-95.14%240.64%2-80.00%22340.00%
Mar 31, 202528-24.32%18,325,858-1.84%472.01%10-41.18%5-
Dec 31, 20243719.35%18,670,034-0.60%482.02%1770.00%5-37.50%
Sep 30, 202431-11.43%18,782,187-16.99%491.39%10-37.50%833.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv47.18K2.46%-1.03K
Vanguard US Total Market Shares ETF861.87K2.25%-1.00
Vanguard Institutional Extnd Mkt Idx Tr7.06K0.37%-3.22K
Fidelity Extended Market Index7.00K0.36%-49.00
Fidelity Total Market Index5.38K0.28%-
Fidelity Enhanced Small Cap ETF90.25K0.24%1.69K
Spartan Extended Market Index Pool F3.06K0.16%49.00
Bridgeway Ultra-Small Company Market60.20K0.16%-
Spartan Extended Market Index Pool E58.62K0.15%1.23K
PGIM Quantitative Solutions US Micro Cap2.38K0.12%2.38K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 06, 2025Nemec Sarah Senior VP, Finance and PAOBuy$686.50
Jun 06, 2025Quinn William P. President, CEO and CFOBuy$686.50
Jun 06, 2024Nemec Sarah Senior VP, Finance and PAOBuy$1.59K
Dec 16, 2024Nemec Sarah Senior VP, Finance and PAOBuy$1.24K
Dec 16, 2024Quinn William P. President, CEO and CFOBuy$1.24K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q22-
2024 Q42-
2024 Q3--
2024 Q2--

BOLT Ownership FAQ


Who Owns Bolt Biotherapeutics?

Bolt Biotherapeutics shareholders are primarily institutional investors at 41.93%, followed by 7.11% insiders and 50.96% retail investors. The average institutional ownership in Bolt Biotherapeutics's industry, Biotech Stocks , is 45.24%, which Bolt Biotherapeutics falls below.

Who owns the most shares of Bolt Biotherapeutics?

Bolt Biotherapeutics’s largest shareholders are Vivo capital (176.06K shares, 9.18%), Sofinnova investments (137.72K shares, 7.18%), and Citadel advisors (2.37M shares, 6.22%). Together, they hold 22.58% of Bolt Biotherapeutics’s total shares outstanding.

Does Blackrock own Bolt Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Bolt Biotherapeutics.

Who is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Nan fung group is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.52% of its assets in 58.35K Bolt Biotherapeutics shares, valued at 310.41K$.

Who is the top mutual fund holder of Bolt Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Bolt Biotherapeutics shares, with 2.46% of its total shares outstanding invested in 47.18K Bolt Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools